Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.
Colevas
A Dimitrios
AD
National Cancer Institute, Investigational Drug Branch, Cancer Therapy Evaluation Program, Bethesda, MD, USA.
Scharf
Orit
O
Schoenfeldt
Mason
M
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D039564:Integrin alphaV / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy; D012910:Snake Venoms / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D039564:Integrin alphaV; D012910:Snake Venoms; C422910:Cilengitide